Eva Renee Barnett

2022

In 2022, Eva Renee Barnett earned a total compensation of $4.4M as Chief Financial Officer at Immunovant.

Compensation breakdown

Bonus$328,027
Option Awards$2,126,272
Salary$198,485
Stock Awards$1,765,800
Other$8,467
Total$4,427,051

Barnett received $2.1M in option awards, accounting for 48% of the total pay in 2022.

Barnett also received $328K in bonus, $198.5K in salary, $1.8M in stock awards and $8.5K in other compensation.

Rankings

In 2022, Eva Renee Barnett's compensation ranked 749th out of 5,756 executives tracked by ExecPay. In other words, Barnett earned more than 87.0% of executives.

ClassificationRankingPercentile
All
749
out of 5,756
87th
Division
Manufacturing
334
out of 3,133
89th
Major group
Chemicals And Allied Products
107
out of 1,419
93rd
Industry group
Drugs
94
out of 1,320
93rd
Industry
Biological Products, Except Diagnostic Substances
21
out of 291
93rd
Source: SEC filing on June 30, 2022.

Barnett's colleagues

We found two more compensation records of executives who worked with Eva Renee Barnett at Immunovant in 2022.

2022

William Macias

Immunovant

Chief Medical Officer

2022

Peter Salzmann

Immunovant

Chief Executive Officer

News

You may also like